I received last week a great study published in January/2017 by KPMG entitled “Pharma Outlook 2030: From evolution to revolution”. The report deals basically with what the authors call the two “seismic shifts” that currently affect the pharmaceutical industry. It also includes a quick but interesting comparison of the impact of technology on two mature […]